Streamline Health Ownership
| STRM Stock | USD 2.78 0.26 8.55% |
Shares in Circulation | First Issued 1995-06-30 | Previous Quarter 58.2 M | Current Value 60.1 M | Avarage Shares Outstanding 17.3 M | Quarterly Volatility 13.9 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Streamline |
Streamline Stock Ownership Analysis
About 24.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.81. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Streamline Health has Price/Earnings (P/E) ratio of 321.67. The entity recorded a loss per share of 4.39. The firm last dividend was issued on the 30th of September 2010. Streamline Health had 1:15 split on the 4th of October 2024. Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia. Streamline Health operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 134 people. To find out more about Streamline Health Solutions contact the company at 888 997 8732 or learn more at https://www.streamlinehealth.net.Besides selling stocks to institutional investors, Streamline Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Streamline Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Streamline Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Streamline Health Quarterly Liabilities And Stockholders Equity |
|
Streamline Health Insider Trades History
About 24.0% of Streamline Health Solutions are currently held by insiders. Unlike Streamline Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Streamline Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Streamline Health's insider trades
Streamline Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Streamline Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Streamline Health Solutions backward and forwards among themselves. Streamline Health's institutional investor refers to the entity that pools money to purchase Streamline Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | State Street Corp | 2024-06-30 | 86.7 K | Northern Trust Corp | 2024-06-30 | 70.7 K | Ubs Group Ag | 2024-06-30 | 46.4 K | Radnor Capital Management, Llc | 2024-06-30 | 30.3 K | Morgan Stanley - Brokerage Accounts | 2024-06-30 | 25 K | Townsquare Capital Llc | 2024-06-30 | 22.3 K | Tower Research Capital Llc | 2024-06-30 | 21.6 K | Susquehanna International Group, Llp | 2024-06-30 | 19.9 K | Two Sigma Securities, Llc | 2024-06-30 | 13.3 K | Harbert Fund Advisors Inc | 2024-06-30 | 4.8 M | Perkins Capital Management Inc | 2024-09-30 | 1.9 M |
Streamline Health Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Streamline Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Streamline Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Streamline Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Streamline Health Outstanding Bonds
Streamline Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Streamline Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Streamline bonds can be classified according to their maturity, which is the date when Streamline Health Solutions has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| MPLX LP 52 Corp BondUS55336VAL45 | View |
Streamline Health Corporate Filings
| 22nd of November 2024 Other Reports | ViewVerify | |
8K | 15th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 1st of November 2024 Other Reports | ViewVerify | |
F4 | 24th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out World Market Map to better understand how to build diversified portfolios, which includes a position in Streamline Health Solutions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Streamline Health. If investors know Streamline will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Streamline Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 12.131 | Earnings Share (4.39) | Revenue Per Share 5.249 | Quarterly Revenue Growth (0.01) | Return On Assets (0.11) |
The market value of Streamline Health is measured differently than its book value, which is the value of Streamline that is recorded on the company's balance sheet. Investors also form their own opinion of Streamline Health's value that differs from its market value or its book value, called intrinsic value, which is Streamline Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Streamline Health's market value can be influenced by many factors that don't directly affect Streamline Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Streamline Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Streamline Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Streamline Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.